Faculty Opinions recommendation of Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial.
2012 ◽
Vol 18
(7)
◽
pp. 1128-1135
◽
Keyword(s):
2003 ◽
Vol 124
(2)
◽
pp. 190-194
◽